Development and internal validation of a prediction model for intravenous contrast-associated acute kidney injury
- PMID: 40824995
- DOI: 10.1002/jhm.70136
Development and internal validation of a prediction model for intravenous contrast-associated acute kidney injury
Abstract
Background: Concerns about contrast-associated acute kidney injury (CA-AKI) may lead to individuals not undergoing necessary contrast-enhanced imaging. Effective risk stratification plays a crucial role in patient management.
Objectives: To develop a prediction model combining the effects of multiple risk factors to predict risk of CA-AKI for individuals undergoing intravenous contrast-enhanced computed tomography (CECT) imaging.
Methods: In this retrospective cohort study, 906 inpatient and outpatient adults who underwent CECT imaging in two tertiary centers, St. Luke's Medical Center-Quezon City and St. Luke's Medical Center-Global City, located in Manila, Philippines, were included. Multivariate logistic regression was used to identify independent predictors for CA-AKI. A p-value ≤ 0.05 was considered significant. Based on the odds ratio, five parameters were identified and included in the model.
Results: The incidence of CA-AKI was 10.38%. A significant association was found between CA-AKI with in-hospital mortality (odds ratio [OR]: 4.23, confidence interval [CI]: 2.59-6.90, p = 0.001) and AKI requiring renal replacement therapy (OR: 3.57, CI: 1.94-6.59, p = 0.001) among admitted patients. Multivariate analysis included reduced estimated glomerular filtration rate (OR = 17.13, p = 0.005), acute heart failure (OR = 9.21, p = 0.006), hypotension (OR = 5.15, p = 0.011), anemia (OR = 4.34, p = 0.004), and use of nephrotoxic antibiotics (OR = 5.82, p = 0.009) in the final prediction model. The prediction model had fair predictive power (area under the curve = 0.737) and good calibration (Hosmer-Lemeshow p-value = 0.418).
Conclusions: This prediction model, incorporating clinical and laboratory parameters, provides a practical tool for estimating CA-AKI risk with fair discrimination and good internal calibration. It may support informed decision-making regarding the risks and benefits of intravenous CECT. External validation is recommended.
© 2025 Society of Hospital Medicine.
References
REFERENCES
-
- Bartels ED, Brun GC, Gammeltoft A, Gjørup PA. Acute annria following intravenous pyelography in a patient with myelomatosis. Acta Med Scand. 2009;150(4):297‐302. doi:10.1111/j.0954-6820.1954.tb18632.x
-
- Davenport MS, Perazella MA, Yee J, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2020;294(3):660‐668. doi:10.1148/radiol.2019192094
-
- Macdonald DB, Hurrell CD, Costa AF, et al. Canadian Association of Radiologists guidance on contrast‐associated acute kidney injury. Can J Kidney Health Dis. 2022;9:3. doi:10.1177/20543581221097455
-
- Wang C, Asch D, Cavallo J, et al. Acr.org. [cited 2023 Mar 4]. https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf
-
- Allen DW, Ma B, Leung KC, et al. Risk prediction models for contrast‐induced acute kidney injury accompanying cardiac catheterization: systematic review and meta‐analysis. Can J Cardiol. 2017;33(6):724‐736. doi:10.1016/j.cjca.2017.01.018
LinkOut - more resources
Full Text Sources